Wednesday, February 25, 2026 | 05:29 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sohini Das

Sohini Das

Sohini Das

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.

Email
Twitter
LinkedIn

Page 92 - Sohini Das

Private health care providers gear up for Covid-19 vaccination drive

The industry, on its part, is drafting out the road map for vaccination and where they can chip in.

Private health care providers gear up for Covid-19 vaccination drive
Updated On : 04 Dec 2020 | 6:05 AM IST

If all goes well, India may get first Covid-19 vaccine by February

AstraZeneca vaccine is likely to cost Rs 500-600 per dose in the private market

If all goes well, India may get first Covid-19 vaccine by February
Updated On : 23 Nov 2020 | 6:10 AM IST

No impact of adverse event on Covid-19 vaccine timelines: Bharat Biotech

The firm said subject was now safe. Though it was reported to the drug regulator within 24 hours, the event turned out to be unrelated to the vaccine.

No impact of adverse event on Covid-19 vaccine timelines: Bharat Biotech
Updated On : 23 Nov 2020 | 12:08 AM IST

Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites

In September, DRL and RDIF had tied up to conduct clinical trials and distribute the vaccine in India.

Tech transfer of Russian Covid vaccine Sputnik V kicks off at Indian sites
Updated On : 20 Nov 2020 | 10:23 PM IST

Pfizer ends vaccine trial with 95% success rate, to apply for approval soon

Pfizer and BioNTech said they plan to submit the data to other regulatory agencies around the world.

Pfizer ends vaccine trial with 95% success rate, to apply for approval soon
Updated On : 19 Nov 2020 | 1:11 AM IST

Moderna's Covid-19 vaccine may come to India through govt route

Players like Indian Immunologicals willing to partner US firm to manufacture here

Moderna's Covid-19 vaccine may come to India through govt route
Updated On : 17 Nov 2020 | 10:24 PM IST

Moderna's Covid vaccine 94.5% effective, edges over Pfizer on storage

Its vaccine's temperature requirements give it an edge over Pfizer's for distribution in India

Moderna's Covid vaccine 94.5% effective, edges over Pfizer on storage
Updated On : 17 Nov 2020 | 1:42 AM IST

Covid-19: Vaccine production is not a problem for India, cold chain is

As India prepares a road map for a Covid-19 vaccination drive next year, the lack of cold chain infrastructure is a key bottleneck

Covid-19: Vaccine production is not a problem for India, cold chain is
Updated On : 17 Nov 2020 | 12:35 AM IST

Covid winter sparks scramble for pvt hospital beds in Delhi, Mumbai stable

Delhi reels under a strong second wave of infections with daily tally of over 8,000 cases, Mumbai seems to be breathing easy with almost one-eighth that number

Covid winter sparks scramble for pvt hospital beds in Delhi, Mumbai stable
Updated On : 14 Nov 2020 | 1:16 AM IST

Serum to have 200 mn doses of AstraZeneca coronavirus vaccine ready by Jan

Pune company recruits over 1,600 participants in India for phase 3 trials of Covishield.

Serum to have 200 mn doses of AstraZeneca coronavirus vaccine ready by Jan
Updated On : 13 Nov 2020 | 12:30 AM IST

Govt announces Rs 900 cr towards research, development of Covid-19 vaccine

The funds for research have been allocated to the Department of Biotechnology as part of the stimulus package announced by the finance minister

Govt announces Rs 900 cr towards research, development of Covid-19 vaccine
Updated On : 12 Nov 2020 | 11:33 PM IST

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

For Siemens, around 50 per cent are first-time buyers, 30 per cent are adding machines for Covid-19

Pandemic pushes up demand for CT scanners; firms gear up to meet surge
Updated On : 11 Nov 2020 | 10:25 PM IST

India's largest pharma IPO worth Rs 6,500 cr set to hit market next week

Fosun-owned Gland Pharma sets price band for its IPO at Rs 1,490-1,500 per share

India's largest pharma IPO worth Rs 6,500 cr set to hit market next week
Updated On : 04 Nov 2020 | 11:05 PM IST

Sun Pharma's Q2 net profit rises 70% on one-time tax credit

Revenues remain flat, sequential improvement in India and US revenues

Sun Pharma's Q2 net profit rises 70% on one-time tax credit
Updated On : 04 Nov 2020 | 1:35 AM IST

Listing can happen in 18-24 months, says Manipal Education's Ranjan Pai

Our focus right now is to complete the transaction and the integration, said Pai

Listing can happen in 18-24 months, says Manipal Education's Ranjan Pai
Updated On : 03 Nov 2020 | 6:05 AM IST

Bengaluru-based Manipal Hospitals to acquire Columbia Asia for Rs 2,100 cr

The deal may mark the exit of US based hospital chain from India

Bengaluru-based Manipal Hospitals to acquire Columbia Asia for Rs 2,100 cr
Updated On : 02 Nov 2020 | 11:08 PM IST

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir

Emergency use authorisation to continue; recently, WHO had raised doubts about efficacy of drug in treatment of Covid-19 patients

DCGI rejects DRL's proposal, denies full marketing rights for Remdesivir
Updated On : 02 Nov 2020 | 11:00 PM IST

Covid-19 vaccine: India begins augmenting its cold chain capacity

While the country already has a huge cold chain set-up, it may not be enough for vaccine delivery

Covid-19 vaccine: India begins augmenting its cold chain capacity
Updated On : 30 Oct 2020 | 6:10 AM IST

Decoded: Why the fear of a second coronavirus wave in India is real

Europe is now suffering from a second wave of the Sars-CoV-2 virus attack

Decoded: Why the fear of a second coronavirus wave in India is real
Updated On : 30 Oct 2020 | 6:10 AM IST

Govt revises PLI scheme for bulk drugs to boost local manufacturing

Industry says revised PLI scheme will attract more MSMEs to invest as minimum investment clause done away with

Govt revises PLI scheme for bulk drugs to boost local manufacturing
Updated On : 29 Oct 2020 | 10:17 PM IST